Your Article Summary
One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations
Transfusion, 06/15/09
Phikulsod S et al. - The performances of the systems and tests indicated that both were acceptable for routine NAT by the National Blood Center, the Thai Red Cross Society. However, the Procleix Ultrio test appeared to be less sensitive than the cobas TaqScreen test for HBV.
Related Articles
New Technology Allows Double Blood Donation
Internet Source, 10/07/09
Relevance Score: 68%%
Blood Diagnosis: Chip-based And Mobile
ScienceDaily, 10/16/09
Relevance Score: 67%%
Declining hepatitis C virus (HCV) prevalence in pregnant women: impact of anti-HCV screening of donated blood
Transfusion, 11/23/09
Relevance Score: 66%%
Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007
Transfusion, 10/13/09
Relevance Score: 66%%
Intraoperative minimal acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery
Middle East Journal of Anesthesiology, 10/14/09
Relevance Score: 65%%
Today in Transfusion Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Application of the bactericidal activity of epsilon-poly-l-lysine to the storage of human platelet concentrates
Transfusion, 11/25/09
Meta-analysis of clinical studies of the purported deleterious effects of "old" (versus "fresh") red blood cells: are we at equipoise?
Transfusion, 11/25/09
Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening
Transfusion, 11/23/09

See Latest Articles